Brokerages predict that Israel Chemicals Ltd. (NYSE:ICL) will report earnings of $0.08 per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Israel Chemicals’ earnings, with estimates ranging from $0.07 to $0.09. Israel Chemicals reported earnings per share of $0.09 during the same quarter last year, which indicates a negative year over year growth rate of 11.1%. The business is expected to report its next quarterly earnings results on Wednesday, February 21st.
On average, analysts expect that Israel Chemicals will report full year earnings of $0.27 per share for the current fiscal year, with EPS estimates ranging from $0.26 to $0.28. For the next fiscal year, analysts anticipate that the company will post earnings of $0.34 per share, with EPS estimates ranging from $0.32 to $0.35. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Israel Chemicals.
Israel Chemicals (NYSE:ICL) last posted its quarterly earnings results on Wednesday, November 8th. The basic materials company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.08 by $0.01. The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Israel Chemicals had a return on equity of 13.20% and a net margin of 4.47%. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period last year, the firm earned $0.09 EPS.
Several research firms have recently commented on ICL. Zacks Investment Research raised Israel Chemicals from a “sell” rating to a “hold” rating in a report on Monday, September 25th. BMO Capital Markets reaffirmed a “hold” rating on shares of Israel Chemicals in a report on Friday, October 6th. Finally, ValuEngine raised Israel Chemicals from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the stock. Israel Chemicals currently has a consensus rating of “Hold” and an average price target of $4.88.
Israel Chemicals (NYSE:ICL) traded down $0.02 on Friday, hitting $4.04. The stock had a trading volume of 95,939 shares, compared to its average volume of 224,471. The company has a quick ratio of 0.70, a current ratio of 1.24 and a debt-to-equity ratio of 0.93. The firm has a market cap of $5,241.15, a PE ratio of 21.26 and a beta of 1.16. Israel Chemicals has a 1-year low of $3.85 and a 1-year high of $4.95.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 20th. Investors of record on Tuesday, December 5th were issued a dividend of $0.044 per share. The ex-dividend date of this dividend was Tuesday, December 5th. This is a boost from Israel Chemicals’s previous quarterly dividend of $0.02. This represents a $0.18 annualized dividend and a yield of 4.36%. Israel Chemicals’s payout ratio is currently 94.74%.
A number of hedge funds have recently modified their holdings of ICL. Russell Investments Group Ltd. raised its holdings in Israel Chemicals by 80.1% during the second quarter. Russell Investments Group Ltd. now owns 40,566 shares of the basic materials company’s stock worth $189,000 after purchasing an additional 18,041 shares during the last quarter. SG Americas Securities LLC raised its holdings in Israel Chemicals by 22.7% during the second quarter. SG Americas Securities LLC now owns 127,013 shares of the basic materials company’s stock worth $601,000 after purchasing an additional 23,465 shares during the last quarter. Comerica Bank raised its holdings in Israel Chemicals by 514.0% during the second quarter. Comerica Bank now owns 82,311 shares of the basic materials company’s stock worth $387,000 after purchasing an additional 68,906 shares during the last quarter. Swiss National Bank raised its holdings in Israel Chemicals by 5.4% during the second quarter. Swiss National Bank now owns 1,928,014 shares of the basic materials company’s stock worth $9,095,000 after purchasing an additional 98,182 shares during the last quarter. Finally, Schroder Investment Management Group raised its holdings in Israel Chemicals by 168.7% during the second quarter. Schroder Investment Management Group now owns 88,674 shares of the basic materials company’s stock worth $1,460,000 after purchasing an additional 55,674 shares during the last quarter. 6.37% of the stock is owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/13/brokerages-expect-israel-chemicals-ltd-icl-to-announce-0-08-eps.html.
Israel Chemicals Company Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines in Spain and the United Kingdom, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers.
Get a free copy of the Zacks research report on Israel Chemicals (ICL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.